Article thumbnail

Structural Basis for Dual-Inhibition Mechanism of a Non-Classical Kazal-Type Serine Protease Inhibitor from Horseshoe Crab in Complex with Subtilisin

By Rajesh T. Shenoy, Saravanan Thangamani, Adrian Velazquez-Campoy, Bow Ho, Jeak Ling Ding and J. Sivaraman

Abstract

Serine proteases play a crucial role in host-pathogen interactions. In the innate immune system of invertebrates, multi-domain protease inhibitors are important for the regulation of host-pathogen interactions and antimicrobial activities. Serine protease inhibitors, 9.3-kDa CrSPI isoforms 1 and 2, have been identified from the hepatopancreas of the horseshoe crab, Carcinoscorpius rotundicauda. The CrSPIs were biochemically active, especially CrSPI-1, which potently inhibited subtilisin (Ki = 1.43 nM). CrSPI has been grouped with the non-classical Kazal-type inhibitors due to its unusual cysteine distribution. Here we report the crystal structure of CrSPI-1 in complex with subtilisin at 2.6 Å resolution and the results of biophysical interaction studies. The CrSPI-1 molecule has two domains arranged in an extended conformation. These two domains act as heads that independently interact with two separate subtilisin molecules, resulting in the inhibition of subtilisin activity at a ratio of 1:2 (inhibitor to protease). Each subtilisin molecule interacts with the reactive site loop from each domain of CrSPI-1 through a standard canonical binding mode and forms a single ternary complex. In addition, we propose the substrate preferences of each domain of CrSPI-1. Domain 2 is specific towards the bacterial protease subtilisin, while domain 1 is likely to interact with the host protease, Furin. Elucidation of the structure of the CrSPI-1: subtilisin (1∶2) ternary complex increases our understanding of host-pathogen interactions in the innate immune system at the molecular level and provides new strategies for immunomodulation

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3082530
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2002). A clogged gutter mechanism for protease inhibitors.
  2. (1999). A Kazal type trypsin inhibitor from the protochordate Ciona intestinalis.
  3. (1994). A Kazal-type inhibitor of human mast cell tryptase: Isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis.
  4. (1993). A Kazaltype inhibitor with thrombin specificity from Rhodnius prolixus.
  5. (2009). A Novel Serine Protease Inhibitor Acts as an Immunomodulatory Switch while Maintaining Homeostasis.
  6. (2005). A two disulfide bridge Kazal domain from Phytophthora exhibits stable inhibitory activity against serine proteases of the subtilisin family.
  7. (1993). Arg15-Lys17-Arg18 turkey ovomucoid third domain inhibits human furin.
  8. (1998). Comparison of x-ray crystal sidechain co-ordinates from a C alpha trace application to model building and sidechain co-ordinates from a C alpha trace application to model building and detection of co-ordinate errors.
  9. (2004). Coot: model-building tools for molecular graphics.
  10. (2009). Crystallization of a nonclassical Kazal-type Carcinoscorpius rotundicauda serine protease inhibitor, CrSPI-1, complexed with subtilisin.
  11. (1998). Crystallography & NMR System (CNS), A new software suite for macromolecular structure determination.
  12. (2004). Current genome-wide analysis on serine proteases in innate immunity.
  13. (1991). Database algorithm for generating protein backbone and side-chain co-ordinates from a C alpha trace application to model building and detection of co-ordinate errors.
  14. (1998). Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexes.
  15. (2009). Domain inhibitory and bacteriostatic activities of the five-domain Kazal-type serine proteinase inhibitor from black tiger shrimp Penaeus monodon.
  16. (1999). ESPript: multiple sequence alignments in PostScript.
  17. (1998). Evolution and phylogeny of defense molecules associated with innate immunity in horseshoe crab.
  18. (2002). Furin at the cutting edge: from protein traffic to embryogenesis and disease.
  19. (1997). Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins.
  20. (2009). Identification and characterization of the lipid-binding property of GrlR, a locus of enterocyte effacement regulator.
  21. (1991). Improved methods for building protein models in electron density maps and the location of errors in these models.
  22. (2001). Insect silk contains both a Kunitz-type and a unique Kazal-type proteinase inhibitor.
  23. (1996). Limulus kexin: a new type of Kex2-like endoprotease specifically expressed in hemocytes of the horseshoe crab.
  24. (2010). Modifying the substrate specificity of Carcinoscorpius rotundicauda serine protease inhibitor domain 1 to target thrombin.
  25. (2010). MolProbity: all-atom structure validation for macromolecular crystallography.
  26. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures.
  27. (2000). Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome.
  28. (1992). Natural protein proteinase inhibitors and their interaction with proteinases.
  29. (2001). New era in pyrogen testing.
  30. (2002). Novel roles of protease inhibitors in infection and inflammation.
  31. (2002). Precursor processing by kex2/furin proteases.
  32. (2006). Proprotein convertases: lessons from knockouts.
  33. (1997). Refinement of macromolecular structures by the maximum-likelihood method.
  34. (1999). Serine proteinase inhibitors in arthropod immunity.
  35. (1994). So ¨derha ¨ll K
  36. So ¨derha ¨ll K, Dushay MS (2004) Coagulation in arthropods: defence, wound closure and healing.
  37. (2002). Solution structure of ascidian trypsin inhibitor determined by nuclear magnetic resonance spectroscopy.
  38. (2005). Structural and functional study of an Anemonia elastase inhibitor, a ‘‘nonclassical’’ Kazal-type inhibitor from Anemonia sulcata.
  39. (2003). Structural basis of inhibition revealed by a 1:2 complex of the two-headed tomato inhibitor-II and subtilisin Carlsberg.
  40. (2005). Structure of the subtilisin Carlsberg-OMTKY3 complex reveals two different ovomucoid conformations.
  41. (2006). Tassanakajon A
  42. (1997). Teplyakov A
  43. (2001). The contribution of proteinase inhibitors to immune defense.
  44. (1987). The covalent structure of the elastase inhibitor from Anemonia sulcata - a ‘‘non-classical’’ Kazal-type protein.
  45. (1987). The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry.
  46. (1986). The primary structure of bdellin B-3 from the leech Hirudo medicinalis.
  47. (2002). The PyMOL Molecular Graphics System DeLano Scientific,
  48. (1996). The role of hemolymph coagulation in innate immunity.
  49. (2005). The structure of the bacteriophage PRD1 spike sheds light on the evolution of viral capsid architecture.
  50. (2009). The ternary structure of the double-headed arrowhead protease inhibitor API-A complexed with two trypsins reveals a novel reactive site conformation.
  51. (1993). Two forms of factor C from the amebocytes of Carcinoscorpius rotundicauda: Purification and characterization.
  52. (1995). Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin.
  53. (2009). Velazquez-Campoy A